4d Molecular Therapeutics In shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in 4d Molecular Therapeutics In by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $8.7M | 428k | 20.26 |
| 2023-09-30 | $7.5M | 586k | 12.73 |
| 2023-06-30 | $8.3M | 457k | 18.07 |
| 2023-03-31 | $7.5M | 440k | 17.14 |
| 2022-12-31 | $10M | 440k | 22.86 |
| 2022-06-30 | $3.6M | 479k | 7.57 |
| 2022-03-31 | $5.6M | 368k | 15.13 |
| 2021-12-31 | $6.4M | 283k | 22.44 |
| 2021-03-31 | $914k | 21k | 43.77 |